TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / CVRx Stock

CVRx Stock

cvrx.comHealthcareFounded: 1900Funding to Date: $384.4MM

CVRx is the developer of a proprietary implantable technology for the treatment of high blood pressure and heart failure

Learn more about CVRx IPO
Register for Details

For more details on financing and valuation for CVRx, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for CVRx.

Register Today

Team

Management Team

John Brintnall
Chief Financial Officer
Julia Stubben
Vice President, European Sales & Marketing
Nadim Yared
President, Chief Executive Officer & Board Member
Joseph DuPay
Senior Vice President, Development & Operations
Jared Oasheim
Controller
Dean Bruhn-Ding
Vice President of Regulatory Affairs and Quality Assurance

Board Members

Geoff Pardo
Gilde Healthcare Partners
Ali Behbahani MD
New Enterprise Associates
John Nehra
New Enterprise Associates
Kadir Kadhiresan Ph.D
Johnson & Johnson Innovation - JJDC
Tom Heyman
Johnson & Johnson Innovation - JJDC
Claudia D'Augusta Ph.D
Ysios Capital
Juan-Pablo Mas
Action Potential Venture Capital
Joseph Slattery
Nadim Yared

Other companies like CVRx in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Colossal Biosciences
Sector
Healthcare
 
 
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
OURA
Sector
Healthcare
 
 
Cytonics
Sector
Healthcare
 
 
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
Precision Neuroscience
Sector
Healthcare
 
 

News

Star Tribune 08/23/2019
At long last, CVRx device gets FDA approval
Barostim device gets FDA nod to treat heart failure by stimulating nerve endings in the neck
Market Screener 06/12/2019
CVRx President and CEO Nadim Yared Named Chairman of the Medical Device Innovation Consortium (MDIC) Board of Directors
PR Newswire 08/09/2016
CVRx® Secures $113 Million in New Financing
/PRNewswire/ -- CVRx, Inc., a private medical device company, has secured equity financing totaling $93 million and a new $20 million debt facility. CVRx plans...

Trending Companies

Frequently Asked Questions